HD-PLC-ALLIANCE
Last year, HD-PLC Alliance *1 , Fukuoka, Japan (Alliance) launched the “Global Strategy Preparatory Office”, a new ad-hoc working group, to support the advancement of IoT migration which is leading to a dramatic growth of the needs for high-speed PLC in various systems such as smart-meter, factory-automation (FA), building-automation (BA), solar power generation, smart-streetlight, smarter-city, smarter-home, etc.
The Alliance announces today several initiatives as part of the development of its global activities.
First, the Alliance will hold an HD-PLC *2 global web seminar (webinar) jointly with IEEE SA*3 on coming Thursday, 18th March to showcase its ecosystem footprint.
-
Event title: [IEEE SA And HD-PLC Alliance Webinar March 2021]
Home Networking, Industrial and Building Automation through HD-PLC (High Speed Powerline Communication)
- Official website: https://hd-plc.org/news/ , https://standards.ieee.org/events/index.html
- Topics covered/Agenda: HD-PLC technology and Standards, Building Automation, Industrial Case Studies, In-home systems, Internet of Things (IoT), HD-PLC licensing program
- Presenter: IEEE 1901 Working Group Chair, Panasonic, MegaChips, Alliance Chair and Manager
The official website has been completely renewed in February this year and the Alliance has increased its presence on the SNS site such as Facebook, LinkedIn to disseminate more information globally.
The Alliance will actively contribute to the activities of global standardization in cooperation with IEEE despite of COVID-19 disaster these days.
Since its establishment in 2007, the Alliance has carried out global activities in Europe, U.S.A, Asia to expand and spread HD-PLC and to ensure interoperability. As a result, the global IEEE Standard 1901*4 was approved in 2010, adopting HD-PLC as core technology. "The IEEE 1901 standard is the FIRST standard that converted scattered initiatives into a profitable industry offering assurance of interoperability to users” said Jean-Philippe Faure, IEEE 1901 Working Group Chair.
In 2012 the HD-PLC technology was adopted in the Chinese national standard GB/T 29265.305-2012 *5 . Additionally, U.S. standard ANSI/CTA 709.8 LON HD-PLC*6 , based on IEEE std 1901, has been approved in 2020. This shows that HD-PLC is broadly recognized as one of most popular global High-speed Power Line Communication standard.
The Alliance has continuously contributed and will continue to contribute to the evolution of the IEEE 1901 standard. "The continuous development of amendments within the IEEE 1901 Working Group consolidates the technology, inspires new uses in new sectors - LON standard - and expands the PLC market to new generations of products.” continued Jean-Philippe Faure. The last achievement was the publication of IEEE Std 1901-2020.
Note:
- The unincorporated association founded by Panasonic Corporation in 2017, which aims to expand and increase the use of HD-PLC and ensure interoperability between equipment with built-in HD-PLC.
- An abbreviation for “High Definition Power Line Communication” originally. HD-PLC™ or HD-PLC™ mark is a registered trademark or trademark of Panasonic Corporation in Japan and in other countries.
- The IEEE (Institute of Electrical and Electronics Engineers, U.S.A) Standards Association.
-
The global standard on high-speed Power Line Communication that adopted HD-PLC as core technology in 2010. The latest revision, IEEE 1901 std-2020, has been published in January 2021.
https://standards.ieee.org/standard/1901-2020.html - IGRS (a communication industry organization in China), the Alliance, Panasonic, etc. worked for this standardization together. It was approved in 2012.
- American National Standards Institute (ANSI) approved as American National Standard (ANS).
View source version on businesswire.com: https://www.businesswire.com/news/home/20210307005013/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Deciphera Presents 2-Year Efficacy and Safety Results from MOTION Phase 3 Study of ROMVIMZA™ (vimseltinib) in Patients with Tenosynovial Giant Cell Tumor (TGCT) at the European Society for Medical Oncology Congress 202518.10.2025 13:00:00 CEST | Press release
– Vimseltinib demonstrated statistically significant and clinically meaningful benefit vs placebo in antitumor response – Ono Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President and COO: Toichi Takino; “Ono”), today announced the two-year efficacy and safety results from its MOTION Phase 3 study of vimseltinib in patients with TGCT in cases where surgical removal of the tumor is not an option will be presented as a poster during the 2025 European Society for Medical Oncology Congress (ESMO), taking place October 17-21 in Berlin, Germany. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251018921529/en/ “These long-term Phase 3 MOTION results add to the established body of evidence supporting vimseltinib as a best-in-class treatment for TGCT,” said Matthew L. Sherman, M.D., Chief Medical Officer of Deciphera. “TGCT often causes debilitating pain, stiffness and impaired mobility and these results demonstrate the dura
ProAmpac Acquires International Paper’s Bag Converting Operations17.10.2025 16:09:00 CEST | Press release
ProAmpac, a global leader in flexible packaging and material science, has acquired the bag converting operations of International Paper (“IP”), a global leader in sustainable packaging. The acquisition expands ProAmpac’s converting capabilities, further advancing the company’s Fiberization of Packaging® strategy and enhancing its ability to deliver customized bag solutions for the grocery, convenience store, and quick-service restaurant markets. “Global demand for reliable, recyclable paper packaging continues to grow rapidly amid evolving consumer expectations and market trends redefining recyclability,” stated Greg Tucker, ProAmpac founder, vice chairman, and chief executive officer. “ProAmpac’s acquisition of IP’s bag operation supports our Fiberization of Packaging initiatives, helping us better serve customers by extending our expertise in material science to the US west coast with additional capabilities and redundancies,” continued Tucker. “IP’s bag business is strong, being bui
Pimicotinib Treatment Demonstrates Deep and Durable Tumor Responses and Continued Improvements in Pain and Function for Patients with TGCT17.10.2025 16:00:00 CEST | Press release
With median follow-up of 14.3 months, pimicotinib demonstrated increasing ORR over time, from 54% at Week 25 to 76.2%Global Phase 3 MANEUVER study demonstrated ongoing improvements in key secondary endpoints including pain and functionApplication for marketing authorization under review by China National Medical Products Administration (NMPA), with additional applications planned in the U.S. and other marketsNot intended for Canada-, UK- or US-based media Merck, a leading science and technology company, today announced the presentation of longer-term results from the global Phase 3 MANEUVER trial evaluating pimicotinib, an investigational colony stimulating factor-1 receptor (CSF-1R) inhibitor in development by Abbisko Therapeutics Co., Ltd., for the treatment of patients with tenosynovial giant cell tumor (TGCT). This latest analysis showed that, with a median follow-up of 14.3 months, the objective response rate (ORR) for people treated with pimicotinib from the beginning of the stud
Vertex Announces Progress in Povetacicept Development Program and Presentation of New Data at American Society of Nephrology Kidney Week17.10.2025 15:04:00 CEST | Press release
- Food and Drug Administration grants rolling review of Biologics License Application for povetacicept in IgA nephropathy; Vertex to submit first module before end of year - - Second pivotal development program of povetacicept underway with Phase 2b/3 trial initiation in primary membranous nephropathy - - Updated data from RUBY-3 trial of povetacicept accepted for late breaking oral presentation; inaxaplin study design and APOL1-mediated kidney disease related data accepted for poster presentation - Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced several important updates across its development program for povetacicept (pove), an investigational recombinant fusion protein therapeutic and dual antagonist of the BAFF (B cell activating factor) and APRIL (a proliferation inducing ligand) cytokines. Pove has demonstrated best-in-class potential in IgA nephropathy (IgAN) and primary membranous nephropathy (pMN) and has pipeline-in-a-product potential across a range of B c
Qualcomm Announces Quarterly Cash Dividend17.10.2025 15:00:00 CEST | Press release
Qualcomm Incorporated (NASDAQ: QCOM) today announced a quarterly cash dividend of $0.89 per common share, payable on December 18, 2025, to stockholders of record at the close of business on December 4, 2025. About Qualcomm Qualcomm relentlessly innovates to deliver intelligent computing everywhere, helping the world tackle some of its most important challenges. Building on our 40 years of technology leadership in creating era-defining breakthroughs, we deliver a broad portfolio of solutions built with our leading-edge AI, high-performance, low-power computing, and unrivaled connectivity. Our Snapdragon® platforms power extraordinary consumer experiences, and our Qualcomm Dragonwing™ products empower businesses and industries to scale to new heights. Together with our ecosystem partners, we enable next-generation digital transformation to enrich lives, improve businesses, and advance societies. At Qualcomm, we are engineering human progress. Qualcomm Incorporated includes our licensing
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom